Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Total Non-Current Liabilities (2019 - 2025)

Historic Total Non-Current Liabilities for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to $622164.0.

  • Bioadaptives' Total Non-Current Liabilities changed N/A to $622164.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $622164.0, marking a year-over-year change of. This contributed to the annual value of $672554.0 for FY2024, which is 1296.69% down from last year.
  • As of Q3 2025, Bioadaptives' Total Non-Current Liabilities stood at $622164.0.
  • Bioadaptives' 5-year Total Non-Current Liabilities high stood at $801959.0 for Q4 2022, and its period low was $502577.0 during Q1 2021.
  • In the last 5 years, Bioadaptives' Total Non-Current Liabilities had a median value of $672554.0 in 2024 and averaged $665733.8.
  • Per our database at Business Quant, Bioadaptives' Total Non-Current Liabilities soared by 4970.0% in 2022 and then tumbled by 1296.69% in 2024.
  • Quarter analysis of 5 years shows Bioadaptives' Total Non-Current Liabilities stood at $684582.0 in 2021, then grew by 17.15% to $801959.0 in 2022, then fell by 3.64% to $772757.0 in 2023, then fell by 12.97% to $672554.0 in 2024, then decreased by 7.49% to $622164.0 in 2025.
  • Its last three reported values are $622164.0 in Q3 2025, $547177.0 for Q2 2025, and $689912.0 during Q1 2025.